October 16, 2020
Seminar on COVID-19 Drug Development at BioJapan Chugai Pharmaceutical is currently discussing with its parent Roche plans to develop Regeneron Pharmaceuticals' antibody cocktail therapy for COVID-19 in Japan that was used to treat US President Donald Trump, a Chugai official...read more